EyeGene,Inc
Develops gene/cell therapies for age-related diseases and preventive vaccines.
185490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185490000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 양지편2로 13 2층, 의왕시
- Website:
- https://eyegene.co.kr/en/
Description
EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-22 00:00 |
투자판단관련주요경영사항( ‘이지-데코린 (EG-Decorin) 창상치료제’ 국내 임상2a상 종료 )
|
Korean | 10.4 KB | ||
| 2022-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2022-11-18 00:00 |
[기재정정]기타경영사항(자율공시)([국책과제 선정] 코로나19 치료제.백신 개발 - 코로나 19 백신 임상 지원 종료 정산)
|
Korean | 12.2 KB | ||
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | 1.1 MB | ||
| 2022-10-19 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 85.1 KB | ||
| 2022-09-06 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 32.2 KB | ||
| 2022-09-06 00:00 |
주식매수선택권부여에관한신고
|
Korean | 17.3 KB | ||
| 2022-09-01 00:00 |
투자판단관련주요경영사항(mRNA 기반 코로나-19 예방백신 (EG-COVID) 남아프리카공화국 부스터 임상 제 1/2a상 시험 계획 승인)
|
Korean | 12.1 KB | ||
| 2022-08-16 00:00 |
반기보고서 (2022.06)
|
Korean | 1.0 MB | ||
| 2022-08-01 00:00 |
주식매수선택권부여에관한신고
|
Korean | 16.1 KB | ||
| 2022-07-15 00:00 |
신주인수권행사(제2회차)
|
Korean | 11.2 KB | ||
| 2022-05-31 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 86.0 KB | ||
| 2022-05-25 00:00 |
본점소재지변경
|
Korean | 4.9 KB | ||
| 2022-05-24 00:00 |
기타경영사항(자율공시)([국책과제 선정]다가 코로나19예방 mRNA백신개발-신변종 감염병대응 mRNA백신 임상지원)
|
Korean | 9.3 KB | ||
| 2022-05-18 00:00 |
[기재정정]사업보고서 (2021.12)
|
Korean | 1.6 MB |
Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EyeGene,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EyeGene,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
